Skip to content
Medical Health Aged Care

Avania Appoints Innovative Operations Strategist Charlene Dark as New Chief Operating Officer

Avania 2 mins read
BILTHOVEN, Netherlands & BOSTON--BUSINESS WIRE--

Avania, the leading global MedTech advisory and clinical development partner, today announced the appointment of operational strategy expert Charlene Dark as chief operating officer (COO).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241203677092/en/

Charlene Dark, newly appointed chief operating officer of Avania. (Photo: Business Wire)

Charlene Dark, newly appointed chief operating officer of Avania. (Photo: Business Wire)

Dark brings over 30 years of experience driving forward-thinking, risk-based strategies that fuel growth and profitability in the clinical development sector. She previously served as executive vice president of global clinical analytics at Clinipace, now Caidya, where she successfully drove commercial growth and operational efficiency of its global clinical analytics solution and spearheaded the development and adoption of the data aggregation and analytics offering.

“I am honored to step into the role of Avania’s COO and work alongside such a talented and dedicated team,” said Dark. “As we navigate the evolving needs of the MedTech industry, my focus will be on fostering innovation and aligning our operations to meet immediate challenges while positioning Avania for sustainable long-term success. Leveraging my experience in implementing actionable strategies and driving measurable outcomes, I am excited to help shape the future of MedTech advisory and development, reinforcing Avania’s reputation as the industry standard.”

“As Avania guides sponsors through every stage of their product’s life cycle, Charlene’s data-driven decision-making, grounded in extensive clinical development experience, will be an asset to our clients and team,” Jason Monteleone, Avania president and CEO, said. “She plays a critical role in our next phase of growth supporting a flexible operating model that meets the diverse needs of our sponsors.”

About Avania

Avania is the leading global MedTech advisory and clinical development partner with a focus on medical devices, diagnostics/IVDs, and digital health. Core offerings include full service clinical research outsourcing, market access, reimbursement, regulatory, and product development advisory services. Avania’s vision is to be your trusted global partner in the evolution of your medical technology from innovation to commercialization to improving patient health and well-being. When you need to advance your medical technology, It Takes Avania.


Contact details:

Holli Kroeker
+1 308-338-2358
pr@scorrmarketing.com

Media

More from this category

  • Medical Health Aged Care
  • 17/01/2025
  • 10:12
Dementia Australia

Country music singer Adam Harvey appointed Dementia Australia Ambassador in honour of his mother

Dementia Australia welcomes renowned country music singer and songwriter Adam Harvey as its newest Ambassador, coinciding with his headline performances at the Tamworth Country Music Festival. Adam, a nine-time Golden Guitar Award winner, has a deeply personal connection to dementia. His mother’s diagnosis inspired him to write his heartfelt song, Remember Me, which he will perform this weekend. Through his music and platform, Adam hopes to bring greater awareness to dementia and its impact on families across Australia. “My mum’s journey with dementia has been deeply challenging for my family, but it has also shown me the importance of understanding,…

  • Contains:
  • Medical Health Aged Care, Sport Recreation
  • 17/01/2025
  • 08:40
Breast Cancer Network Australia

World-First Data: Supervised exercise program for people with incurable breast cancer reveals significant health and economic benefits.

17January, 2025 A world-first study has revealed that two hours of supervised exercise per week significantly benefits people with metastatic breast cancer, improving quality of life while reducing healthcare costs. The PREFERABLE-EFFECT trial, involving 357 participants worldwide, including 135 Australians, is the most extensive exercise study conducted for this population. Participants completed a nine-month program of supervised aerobic, resistance, and balance exercises twice a week, compared to those following general activity advice. Participants in the supervised exercise program experienced significant improvements in quality of life, with reductions in debilitating symptoms such as fatigue, pain, and emotional distress, enabling them to…

  • Medical Health Aged Care
  • 17/01/2025
  • 01:40
King Faisal Specialist Hospital & Research Centre

King Faisal Specialist Hospital and Research Centre Performs the World’s First Robotic-Assisted Artificial Heart Pump Implantation

RIYADH, Saudi Arabia, Jan. 16, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed the world’s first robotic-assisted implantation of an artificial heart pump (HeartMate 3) developed by Abbott, a groundbreaking procedure that marks a significant advancement in medical technology and patient care.The surgery was performed on a 35-year-old man who had been hospitalized for 120 days due to advanced heart failure, which had also led to kidney and lung function deterioration. Thanks to this innovative surgical procedure, the patient is now on track to fulfill his dream of returning home to…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.